News Chart Curable. Inc.

Equities

A086460

KR7086460003

End-of-day quote Korea S.E. Other stock markets 23:00:00 01/07/2024 BST			5-day change	1st Jan Change
4,200 ^KRW	0.00%		-6.56%	-36.07%

2023	Curable. Inc. agreed to acquire 8.5% stake in Pharma Biotech Korea Co., Ltd from Pharma Biotech Korea for KRW 8.5 billion.	CI
2023	Curable. Inc. announced that it has received KRW 5.0009986 billion in funding from GW Vitek CO.,LTD.	CI

9f4883c0348d0e67de2b55d6d.GHCG3cCe5tZGt-3crBfOAzjS3uGzrJKa69flDLpkmnc.KjT_mI7K1uce2tu-wm2hT3K7tpLC483wma-TXs1R3D9rHu-ts_LR4xH6vA~7b6217fe6ed8d58ff0272b89bb94d79d